Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68012929
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Pharmaceutical News
India imposes anti-dumping duties on Chinese-made vitamin A palmitate.2025-06-12
The latest news: vitamin C involution is serious, which has attracted the attention of relevant departments.2025-06-12
Latest news: June 12th, Zhejiang Weishi Bio-vitamin E feed grade latest price.2025-06-12
The latest news: domestic vitamin C companies have suspended their quotations.2025-06-12
BASF's supply of β -ionone will depend on the signing of the agreement.2025-06-06
One-time trial production of Workshop 201 of Gaolan Port Base of Zhuhai Federal Pharmaceutical Company was successful (sulbactam sodium)2025-05-29
The latest news: NHU cystine production line will be stopped for maintenance in June 2025.2025-05-29
Latest news: NHU has officially entered the leucine market and is expected to ship in the third quarter.2025-05-29
The latest news: NHU cystine production line will be stopped for maintenance in June 2025.2025-05-29
Tianxin Pharmaceutical Co., Ltd.: Compared with the same period of last year2025-05-16
The latest news: Xinfu Technology Calcium Pantothenate (calcium pantothenate B5)5 lowered its external quotation from May 16th.2025-05-16
Jindawei coenzyme Q10 technical transformation and expansion project has been completed, and it is currently producing at full capacity.2025-05-14
Jin Dawei: Vitamin A and Vitamin D3 are currently produced at full capacity.2025-05-14
Guangji Pharmaceutical's operating income in 2024 was 638 million yuan, with a net profit loss, and the market price of vitamin B2 was in a downturn.2025-04-30
Shandong NHU will overhaul the vitamin E production line in early June.2025-04-15
Novartis plans to expand its US-based manufacturing and R&D footprint with a total investment of $23B over the next 5 years2025-04-15
DSM-Fenmeiyi's factory for producing vitamin A and vitamin E precursors will be discontinued.2025-04-09
Garden creatures: what is the capacity of vitamin D3 feed after expansion?2025-04-09
Garden creatures: biotin and vitamin B6 specify the production time2025-04-09
NHU: The main vitamin series products are in the US tariff exemption list.2025-04-09
Major vitamin products are included in the US tariff exemption list.2025-04-09
Three major domestic manufacturers of nicotinamide stopped reporting.2025-04-03
Folic acid has mainstream manufacturers to resume quotation.2025-03-31
Jiangxi Tianxin Pharmaceutical will stop reporting and signing vitamin E products from now on.2025-03-25
Wanhua Chemical Vitamin A has been put into production recently.2025-03-18
Shanghai FIC: No quotation was made at the vitamin C exhibition, but the factory withdrew the previous quotation.2025-03-18
Grain Rain Bio-Health Co-production Project was completed, mainly including maltodextrin, psicose, glucose and sorbitol.2025-03-14
Inner Mongolia Yiyuan Bio invested 110 million yuan to build a new production project of chondroitin and collagen peptide.2025-03-14
FDA plans to cancel the Self-GRAS certification, and synthetic biological products have great influence.2025-03-14
BASF announced the resumption of vitamin A production in early April 2025 as originally planned.2025-03-14
BASF announced the resumption of vitamin E production ahead of schedule.2025-03-14
BASF announced the rumor of vitamin E, and the restart is scheduled for mid-May 2025.2025-03-13
4624个 页次:1/14532个/页 首页 上一页 下一页 尾页 转到:
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch
④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463